PepGen Total Assets Growth & History (PEPG)
PepGen's total assets was $173.9M for fiscal 2025.
View full PepGen company overviewPepGen annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $173.9M | $23.0M | +15.26% |
| 2024 | 2024-12-31 | $150.9M | $7.8M | +5.47% |
| 2023 | 2023-12-31 | $143.1M | −$74.4M | −34.21% |
| 2022 | 2022-12-31 | $217.4M | $73.8M | +51.38% |
| 2021 | 2021-12-31 | $143.6M | — | — |
PepGen quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $141.4M | $39.2M | +38.30% |
| Q1 2026 | 2026-03-31 | $156.3M | $28.9M | +22.69% |
| Q4 2025 | 2025-12-31 | $173.9M | $23.0M | +15.26% |
| Q3 2025 | 2025-09-30 | $190.1M | $19.8M | +11.64% |
| Q2 2025 | 2025-06-30 | $102.2M | −$91.3M | −47.16% |
| Q1 2025 | 2025-03-31 | $127.4M | −$79.6M | −38.46% |
| Q4 2024 | 2024-12-31 | $150.9M | $7.8M | +5.47% |
| Q3 2024 | 2024-09-30 | $170.2M | $6.0M | +3.63% |
| Q2 2024 | 2024-06-30 | $193.5M | $11.4M | +6.27% |
| Q1 2024 | 2024-03-31 | $207.0M | $6.0M | +2.96% |
| Q4 2023 | 2023-12-31 | $143.1M | −$74.4M | −34.21% |
| Q3 2023 | 2023-09-30 | $164.3M | −$44.2M | −21.20% |
| Q2 2023 | 2023-06-30 | $182.1M | −$48.7M | −21.11% |
| Q1 2023 | 2023-03-31 | $201.0M | $69.2M | +52.44% |
| Q4 2022 | 2022-12-31 | $217.4M | $73.8M | +51.38% |
| Q3 2022 | 2022-09-30 | $208.5M | — | — |
| Q2 2022 | 2022-06-30 | $230.8M | — | — |
| Q1 2022 | 2022-03-31 | $131.9M | — | — |
| Q4 2021 | 2021-12-31 | $143.6M | — | — |
PepGen total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's total assets increased from $143.6M to $173.9M, a change of $30.3M. The latest reported quarter, Q2 2026, shows $141.4M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...